EUTM file information
018281301
RYAXTYVO
July 30, 2020
Trademark Summary
The trademark application RYAXTYVO was filed by Aprea Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 7, 2020, and it was registered by office on December 15, 2020 without any oppositions.
The application was filed in English (French was selected as the second language).
Deletion of the representative of the trademark registration was recorded on January 6, 2021.
Goods And Services
- The mark was filed in class 5 with following description of goods:
- Pharmaceutical preparations and substances for the treatment of blood diseases, cancers and tumors
- Tumor suppressing agents
- Pharmaceuticals, namely, cell death inducers.
